Hyperketonemia decreases mitochondrial membrane potential and its normalization with chromium (III) supplementation in monocytes

Molecular and Cellular Biochemistry

Volumn 349, Issue 1-2, 2011, Pages 77-82

  Rains, Justin L ^a   Jain, Sushil K ^a  

^a LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

Author keywords

Chromium; Diabetes; Ketosis; Mitochondrial membrane potential

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETOACETIC ACID; CHROMIUM;

ABNORMALLY HIGH SUBSTRATE CONCENTRATION IN BLOOD; ARTICLE; CONTROLLED STUDY; FLOW CYTOMETRY; GLUCOSE METABOLISM; HUMAN; HUMAN CELL; HYPERKETONEMIA; MITOCHONDRIAL MEMBRANE POTENTIAL; MONOCYTE;

3-HYDROXYBUTYRIC ACID; ACETOACETATES; CELL SURVIVAL; DIETARY SUPPLEMENTS; HUMANS; KETOSIS; MEMBRANE POTENTIAL, MITOCHONDRIAL; MONOCYTES; NICOTINIC ACIDS; ORGANOMETALLIC COMPOUNDS; U937 CELLS;

ANIMALIA;

EID: 79952283172     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-010-0662-8     Document Type: Article

References (42)

1. J-a Kim Y Wei JR Sowers 2008 Role of mitochondrial dysfunction in insulin resistance Circ Res 102 4 401 414 1:CAS:528:DC%2BD1cXitl2js70%3D 10.1161/CIRCRESAHA.107.165472 18309108 (Pubitemid 351651099)
2. N Turner LK Heilbronn 2008 Is mitochondrial dysfunction a cause of insulin resistance? Trends Endocrinol Metab 19 9 324 330 1:CAS:528: DC%2BD1cXht1KltrfE 10.1016/j.tem.2008.08.001 18804383
3. K Morino Kitt Falk Petersen Sylvie Dufour Douglas Befroy Jared Frattini Nadine Shatzkes Susanne Neschen Morris F White Stefan Bilz Saki Sono Marc Pypaert Gerald I Shulman 2005 Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents J Clin Invest 115 12 3587 3593 1:CAS:528:DC%2BD2MXhtlSqtLjN 10.1172/JCI25151 16284649 (Pubitemid 43121847)
4. J Szendroedi AI Schmid M Meyerspeer C Cervin M Kacerovsky G Smekal S Graser-Lang L Groop M Roden 2009 Impaired mitochondrial function and insulin resistance of skeletal muscle in mitochondrial diabetes Diabetes Care 32 4 677 679 1:CAS:528:DC%2BD1MXltFSks78%3D 10.2337/dc08-2078 19131470
5. M Mogensen K Sahlin M Fernstrom D Glintborg BF Vind H Beck-Nielsen K Hojlund 2007 Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes Diabetes 56 6 1592 1599 1:CAS:528: DC%2BD2sXmtlKhsrg%3D 10.2337/db06-0981 17351150 (Pubitemid 46842617)
6. MR Duchen 2004 Roles of mitochondria in health and disease Diabetes 53 90001 S96 102 1:CAS:528:DC%2BD2cXhtlGqsbY%3D 10.2337/diabetes.53.2007.S96 14749273
7. BB Lowell GI Shulman 2005 Mitochondrial dysfunction and type 2 diabetes Science 307 5708 384 387 1:CAS:528:DC%2BD2MXksFyhtw%3D%3D 10.1126/science. 1104343 15662004 (Pubitemid 40139974)
8. J Lim J Lee Y Suh W Kim J Song M Jung 2006 Mitochondrial dysfunction induces aberrant insulin signalling and glucose utilisation in murine C2C12 myotube cells Diabetologia 49 8 1924 1936 1:CAS:528:DC%2BD28Xms1Oisbo%3D 10.1007/s00125-006-0278-4 16736133 (Pubitemid 44025048)
9. SR Pieczenik J Neustadt 2007 Mitochondrial dysfunction and molecular pathways of disease Exp Mol Pathol 83 1 84 92 1:CAS:528:DC%2BD2sXmtVOrt7c%3D 10.1016/j.yexmp.2006.09.008 17239370 (Pubitemid 46842959)
10. B Sirikul BA Gower GR Hunter DE Larson-Meyer BR Newcomer 2006 Relationship between insulin sensitivity and in vivo mitochondrial function in skeletal muscle Am J Physiol Endocrinol Metab 291 4 E724 E728 1:CAS:528:DC%2BD28XhtFarsL%2FP 10.1152/ajpendo.00364.2005 16705059 (Pubitemid 44484913)
11. RACN Anderson NA Bryden MM Polansky N Cheng J Chi J Feng 1997 Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes Diabetes 46 1786 1791 1:CAS:528: DyaK2sXntVKisbo%3D 10.2337/diabetes.46.11.1786 9356027 (Pubitemid 27456412)
12. W Ding Z Chai P Duan W Feng Q Qian 1998 Serum and urine chromium concentrations in elderly diabetics Biol Trace Elem Res 63 3 231 237 1:CAS:528:DyaK1cXnslyqtL8%3D 10.1007/BF02778941 9840819 (Pubitemid 28533355)
13. C Ekmekcioglu C Prohaska K Pomazal I Steffan G Schernthaner W Marktl 2001 Concentrations of seven trace elements in different hematological matrices in patients with type 2 diabetes as compared to healthy controls Biol Trace Elem Res 79 3 205 219 1:CAS:528:DC%2BD3MXjsVeksro%3D 10.1385/BTER:79:3:205 11354346 (Pubitemid 32375059)
14. A Pineau O Guillard J Risse 1992 A study of chromium in human cataractous lenses and whole blood of diabetics, senile, and normal population Biol Trace Elem Res 32 1 133 138 1:STN:280:DyaK383msFCqtQ%3D%3D 10.1007/BF02784597 1375049
15. WT Cefalu ZQ Wang XH Zhang LC Baldor JC Russell 2002 Oral Chromium picolinate improves carbohydrate and lipid metabolism and enhances skeletal muscle Glut-4 translocation in obese, hyperinsulinemic (JCR-LA Corpulent) Rats J Nutr 132 6 1107 1114 1:CAS:528:DC%2BD38XksFWns7g%3D 12042418 (Pubitemid 34606436)
16. D Lamson S Plaza 2002 The safety and efficacy of high-dose chromium Alternative Medicine Review J Clin Ther 7 3 218 235 (Pubitemid 34747610)
17. NA Lee CA Reasner 1994 Beneficial effect of chromium supplementation on serum triglyceride levels in NIDDM Diabetes Care 17 12 1449 1452 1:STN:280:DyaK2M7ovVKrtg%3D%3D 10.2337/diacare.17.12.1449 7882815 (Pubitemid 24369730)
18. EG Offenbacher FX Pi-Sunyer 1980 Beneficial effect of chromium-rich yeast on glucose tolerance and blood lipids in elderly subjects Diabetes 28 919 925 10.2337/diabetes.29.11.919 (Pubitemid 11022290)
19. JB Vincent 1999 Mechanisms of chromium action: low-molecular-weight chromium-binding substance J Am Coll Nutr 18 1 6 12 1:CAS:528:DyaK1MXhs1Cksb8%3D 10067653 (Pubitemid 29088680)
20. KN Jeejeebhoy 1999 Chromium and parenteral nutrition J Trace Elem Exp Med 12 2 85 89 1:CAS:528:DyaK1MXjtVCru7s%3D 10.1002/(SICI)1520-670X(1999)12: 2<85::AID-JTRA5>3.0.CO;2-Z (Pubitemid 29231777)
21. SK Jain JL Rains JL Croad 2007 Effect of chromium niacinate and chromium picolinate supplementation on lipid peroxidation, TNF-[alpha], IL-6, CRP, glycated hemoglobin, triglycerides, and cholesterol levels in blood of streptozotocin-treated diabetic rats Free Radic Biol Med 43 8 1124 1131 1:CAS:528:DC%2BD2sXhtVCisLjF 10.1016/j.freeradbiomed.2007.05.019 17854708 (Pubitemid 47374434)
22. MS Candiloros H N Zeghari M Donner P Drouin O Ziegler 1995 Decreased erythrocyte membrane fluidity in poorly controlled IDDM. Influence of ketone bodies Diabetes Care 18 4 549 551 10.2337/diacare.18.4.549 7497868
23. CA Newton P Raskin 2004 Diabetic ketoacidosis in type 1 and type 2 diabetes mellitus: clinical and biochemical differences Arch Intern Med 164 17 1925 1931 1:CAS:528:DC%2BD2cXovVCjs70%3D 10.1001/archinte.164.17.1925 15451769 (Pubitemid 39274364)
24. G Umpierrez A Kitabchi 2003 Diabetic ketoacidosis: risk factors and management strategies Treat Endocrinol 2 2 95 108 10.2165/00024677-200302020- 00003 15871546 (Pubitemid 37055612)
25. Z Yared J Chiasson 2003 Ketoacidosis and the hyperosmolar hyperglycemic state in adult diabetic patients. Diagnosis and treatment Minervia Med 94 6 409 418 1:STN:280:DC%2BD2c%2Fos1KqtA%3D%3D (Pubitemid 38506511)
26. SK Jain K Kannan 2001 Chromium chloride inhibits oxidative stress and tnf-[alpha] secretion caused by exposure to high glucose in cultured U937 monocytes Biochem Biophys Res Commun 289 3 687 691 1:CAS:528: DC%2BD3MXos1amsrY%3D 10.1006/bbrc.2001.6026 11726202 (Pubitemid 33152288)
27. K Kannan SK Jain 2004 Effect of vitamin B6 on oxygen radicals, mitochondrial membrane potential, and lipid peroxidation in H2O2-treated U937 monocytes Free Radic Biol Med 36 4 423 428 1:CAS:528:DC%2BD2cXht1yqsbk%3D 10.1016/j.freeradbiomed.2003.09.012 14975445 (Pubitemid 38224514)
28. SK Jain JL Rains JL Croad 2007 High glucose and ketosis (acetoacetate) increases, and chromium niacinate decreases, IL-6, IL-8, and MCP-1 secretion and oxidative stress in U937 monocytes Antioxid Redox Signal 9 10 1581 1590 1:CAS:528:DC%2BD2sXhtVKqs7bM 10.1089/ars.2007.1577 17665966 (Pubitemid 47462963)
29. M Jennifer MJS Stephens PJ Watkins 1971 Relationship of blood acetoacetate and 3-hydroxybutyrate in diabetes Diabetes 20 7 485 489
30. L Lori 1999 Ketone bodies: a review of physiology, pathophysiology and application of monitoring to diabetes Diabetes Metab Res Rev 15 6 412 426 10.1002/(SICI)1520-7560(199911/12)15:6<412::AID-DMRR72>3.0.CO;2-8
31. MA Abdelmegeed SK Kim KJ Woodcroft RF Novak 2004 Acetoacetate activation of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in primary cultured rat hepatocytes: role of oxidative stress J Pharmacol Exp Ther 310 2 728 736 1:CAS:528:DC%2BD2cXmtVyktr0%3D 10.1124/jpet.104.066522 15051799 (Pubitemid 38988919)
32. WH Hoffman C Cheng GG Passmore JE Carroll D Hess 2002 Acetoacetate increases expression of intercellular adhesion molecule-1 (ICAM-1) in human brain microvascular endothelial cells Neurosci Lett 334 2 71 74 1:CAS:528:DC%2BD38XosFClur0%3D 10.1016/S0304-3940(02)00816-9 12435474 (Pubitemid 35341624)
33. SK Jain K Kannan G Lim 1998 Ketosis (acetoacetate) can generate oxygen radicals and cause increased lipid peroxidation and growth inhibition in human endothelial cells Free Radic Biol Med 25 9 1083 1088 1:CAS:528: DyaK1cXotVejtL8%3D 10.1016/S0891-5849(98)00140-3 9870562 (Pubitemid 28558335)
34. SK Jain K Kannan G Lim J Matthews-Greer R McVie JA Bocchini Jr 2003 Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic patients and secretion by acetoacetate-treated cultured U937 monocytes Diabetes Care 26 7 2139 2143 1:CAS:528:DC%2BD3sXlvFCjurs%3D 10.2337/diacare.26.7.2139 12832326 (Pubitemid 41184265)
35. SK Jain K Kannan G Lim R McVie JA Bocchini Jr 2002 Hyperketonemia increases tumor necrosis factor-{alpha} secretion in cultured u937 monocytes and type 1 diabetic patients and is apparently mediated by oxidative stress and cAMP deficiency Diabetes 51 7 2287 2293 1:CAS:528:DC%2BD38Xlt1WksLg%3D 10.2337/diabetes.51.7.2287 12086962 (Pubitemid 34729037)
36. FB Stentz GE Umpierrez R Cuervo AE Kitabchi 2004 Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises Diabetes 53 8 2079 2086 1:CAS:528:DC%2BD2cXmtFGqtrg%3D 10.2337/diabetes.53.8.2079 15277389 (Pubitemid 38970758)
37. SK Jain R McVie 1999 Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients Diabetes 48 9 1850 1855 1:CAS:528:DyaK1MXmtVaitbs%3D 10.2337/diabetes.48.9.1850 10480618 (Pubitemid 29415207)
38. R Mossop 1983 Effects of chromium III on fasting blood glucose, cholesterol and cholesterol HDL levels in diabetics Cent Afr J Med 29 4 80 82 1:STN:280:DyaL3s3osFeisA%3D%3D 6883494 (Pubitemid 13004763)
39. JB Vincent 2004 Recent advances in the nutritional biochemistry of trivalent chromium Proc Nutr Soc 63 01 41 47 1:CAS:528:DC%2BD2cXktFGlurs%3D 10.1079/PNS2003315 15070438 (Pubitemid 38543872)
40. Office of dietary supplements chromium and diabetes workshop summary (1999) http://odsodnihgov/pubs/conferences/chromium-diabetes.html Natcher Conference Center, National Institutes of Health
41. JB Vincent 2000 Quest for the molecular mechanism of chromium action and its relationship to diabetes Nutr Rev 58 3 67 72 1:STN:280: DC%2BD3c3nt1yjsg%3D%3D 10.1111/j.1753-4887.2000.tb01841.x 10812920 (Pubitemid 30230942)
42. SK Jain JL Croad T Velusamy JL Rains R Bull 2010 Chromium dinicocysteinate supplementation can lower blood glucose, CRP, MCP-1, ICAM-1, creatinine, apparently mediated by elevated blood vitamin C and adiponectin and inhibition of NFkB, Akt, and Glut-2 in livers of zucker diabetic fatty rats Mol Nutr Food Res 54 9 1371 1380 1:CAS:528:DC%2BC3cXhtFWqtb3J 10.1002/mnfr.200900177 20306473